Title : Effects of delayed-release dimethyl fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies.

Pub. Date : 2014 Dec 1

PMID : 25315404






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 FINDINGS: The integrated analysis included 2301 patients treated with delayed-release DMF BID (n = 769) or TID (n = 761) or placebo (n = 771). Dimethyl Fumarate BH3 interacting domain death agonist Homo sapiens